RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Impact of risk minimisation measures on the use of strontium ranelate in Europe
Berencsi, K., Sami, A., Ali, M. S., Marinier, K., Deltour, N., Perez-Gutthann, S., Pedersen, L., Rijnbeek, P., Van der Lei, J., Lapi, F., Simonetti, M., Reyes, C., Sturkenboom, M. C. J. M., & Prieto-Alhambra, D. (2020). Correction to: Impact of risk minimisation measures on the use of strontium ranelate in Europe: A multi-national cohort study in 5 EU countries by the EU-ADR Alliance. Osteoporosis International, 31(4), 799. https://doi.org/10.1007/s00198-020-05314-2
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.
